Top compounds associated with response to LILRB2


Feature Type Standardized
Nominal ANOVA
mRNA linifanib GDSC1000 pan-cancer AAC 0.33 1e-21
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.35 1e-11
mRNA AC220 GDSC1000 pan-cancer AAC 0.23 4e-11
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.19 5e-09
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.2 1e-08
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.2 1e-08
mRNA XL-184 GDSC1000 pan-cancer AAC 0.19 3e-08
mRNA ATRA GDSC1000 pan-cancer AAC 0.19 6e-08
mRNA BIX02189 GDSC1000 pan-cancer AAC 0.16 2e-07
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.26 4e-07
Download CSV